seen from T1
seen from United States
seen from T1
seen from China
seen from Yemen
seen from Greece
seen from United States
seen from Singapore
seen from United States
seen from Netherlands
seen from Singapore
seen from China
seen from T1
seen from United States
seen from Yemen
seen from United States
seen from Singapore
seen from United States
seen from China
seen from Italy
KeraStat® Gel is a sterile, non-implantable, keratin based hydrogel wound dressing intended to act as a protective covering in the management of a variety of partial thickness dermal wounds. When applied, KeraStat® Gel covers the wound and facilitates a moist wound environment for the management of partial thickness wounds. Learn More: https://www.keranetics.com/kerastat-gel/
The global radiodermatitis market is expected to reach US$ 472.8 Mn by the end of 2027.
RADIODERMATITIS MARKET ANALYSIS
Radiodermatitis, otherwise called x-beam dermatitis, radiation dermatitis, radiation-incited skin responses, or radiation injury, is a reaction of outer pillar ionizing radiation. Radiotherapy, utilized in the treatment of malignant growth or different ailments, is a significant reason for radiodermatitis. The condition can likewise be a consequence of atomic assaults and debacles.
The worldwide radiodermatitis showcase is assessed to represent US$ 360.5 Mn as far as worth and is relied upon to reach US$ 472.8 Mn before the finish of 2027.
Worldwide Radiodermatitis Market: Drivers
Expanding pervasiveness of malignant growth is relied upon to push development of the worldwide radiodermatitis showcase over the gauge time frame. For example, as indicated by the American Cancer Society, in 2019, there will be an expected 1,762,450 new malignancy cases analyzed and 606,880 disease passings in the U.S.
In addition, R&D of new treatments for the treatment of radiodermatitis is likewise expected to help in development of the market. For example, in December 2019, Kannalife, Inc. recorded another U.S. Patent for its restrictive and novel CBD-like atoms for the treatment of radiodermatitis and other skin issues.
Skin operators held predominant situation in the worldwide radiodermatitis showcase in 2019, representing 70.5% offer as far as worth, trailed by dressing and oral medicine, individually
Figure 1. Worldwide Radiodermatitis Market Share (%), by Value, result Type, 2019
Worldwide Radiodermatitis Market: Restraints
Presentation of better radiation treatment gear is required to upset development of the worldwide radiodermatitis advertise. The seriousness and likeliness to create radiodermatitis can be either tolerant related or treatment-related. The treatment-related variables incorporate the sort and nature of radiation shaft and the area and size of the treatment field. Present day radiotherapy methods, which incorporate power balanced radiation treatment (IMRT) and proton treatment, can decrease the hazard for radiodermatitis by more precisely focusing on tumor. Such situation is relied upon to block development of the market.
Besides, significant expense dressings, for example, nectar impregnated dressings and silicone dressings is likewise expected to restrain development of the market.
Worldwide Radiodermatitis Market: Opportunities
Research and development in radiodermatitis is relied upon to offer worthwhile development open doors for players in the worldwide radiodermatitis showcase. For example, Jay Pharma is relied upon to start a pilot study based on radiodermatitis in the second 50% of 2020.
Besides, putting resources into making mindfulness in regards to radiation-initiated skin harm among guardians and patients in districts with normal standard consideration practices, for example, Asia Pacific, Latin America, and Middle East and Africa is likewise expected to help in development of the market.
The worldwide radiodermatitis showcase was esteemed at US$ 346.9 Mn in 2019 and is figure to arrive at an estimation of US$ 472.8 Mn by 2027 at a CAGR of 3.9% somewhere in the range of 2020 and 2027.
Figure 2. Worldwide Radiodermatitis Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027
Market Trends/Key Takeaways
The solution of skin items is high for the treatment of radiodermatitis. In spite of inadequate proof to help a specific item's utilization, skin steroids and emollients are the most recommended operators worldwide for the treatment of radiodermatitis. Aloe vera gel is utilized as an elective home grown cure. Gels can be valuable in seborrhoeic regions, while creams can be utilized in territories outside skin folds and seborrhoeic zones.
Over-the-counter (OTC) items are more favored than solution items in the treatment of radiodermatitis. This can be ascribed to informal proposals, simple accessibility of OTC items online just as from neighborhood drug stores. Hydrophilic creams sooth tingling and redness and are accessible OTC.
Worth Chain Analysis
The Value Chain for radiation dermatitis items starts from acquirement of crude material, which would incorporate API for oral medication and silicone/hydrogel for silicone and hydrogel dressings. The material passes the phases of R&D, fabricating, flexibly chain lastly is conveyed to the end-clients in facilities, emergency clinics or by means of retail locations (block and mortar just as online stores).
Worldwide Radiodermatitis Market: Competitive Landscape
Significant players working in the worldwide radiodermatitis advertise incorporate, Acelity, Inc. (3M), BMG Pharma S.r.l., ConvaTec Group PLC, DermaSciences Inc. (Integra LifeSciences Holdings Corporation), Intermed Pharmaceuticals, Molnlycke Health Care, Smith and Nephew Plc, Stratpharma AG, Kannalife, Inc., and Jay Pharma
Worldwide Radiodermatitis Market: Key Developments
Significant players in the market are centered around receiving M&A methodologies to extend their item portfolio. For example, in October 2019, 3M procured Acelity, Inc. also, its KCI auxiliaries.
Additionally, in September 2019, Integra LifeSciences Holdings Corporation obtained Rebound Therapeutics, an engineer of single-utilize clinical gadgets that empower insignificantly intrusive access in neurosurgery.
About Us- Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.
Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Phone no- +1-206-701-6702
email Id- [email protected]
Is Aloe Vera for Radiotherapy-Related Skin Reactions Effective?
Cancer ABCs often is asked if the use of aloe vera might be useful for the treatment of or the prevention of radiation dermatitis of the skin in patients undergoing radiation treatment.
Research shows that aloe vera alone is ineffective and may worsen skin reactions from radiation treatment. Research has shown that the cleansing the skin daily with mild moisturizing soaps is most beneficial.
Evidence supporting the use of aloe vera for the prevention and treatment of radiotherapy-related skin effects is controversial. In a 3-arm randomized study that compared a moist aloe extract with a dry skincare regimen and placebo found aloe was not useful for prevention or treatment in patients with breast cancer.(1)
However, a recent study did find that aloe vera was moderately effective when used in combination with mild soap vs. soap alone.(2) These authors also reported that aloe vera might be useful in patients whose cumulative radiation doses are more than 2700 cGy and for patients who experience acute radiation proctitis.
Reference
1. Hoopfer D, Holloway C, Gabos Z, et al. Three-arm randomized phase III trial: quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy. Clinical Breast Cancer. 2015;15(3):181-190.e1-4. 2. Farrugia CE,
2. Burke ES, Haley ME, Bedi KT, Gandhi, MA. The use of aloe vera in cancer radiation: an updated comprehensive review. Complement Ther Clin Pract. 2019;35:126-130.
